CTOR
Citius Oncology Inc.

1,398
Mkt Cap
$89.04M
Volume
86,692.00
52W High
$6.19
52W Low
$0.5506
PE Ratio
-3.11
CTOR Fundamentals
Price
$1.05
Prev Close
$1.08
Open
$1.11
50D MA
$1.20
Beta
-2.43
Avg. Volume
840,223.82
EPS (Annual)
-$0.338
P/B
1.95
Loading...
Loading...
News
all
press releases
Short Interest in Citius Oncology, Inc. (NASDAQ:CTOR) Expands By 51.2%
Citius Oncology, Inc. (NASDAQ:CTOR - Get Free Report) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totaling 983,877 shares, a...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·15d ago
News Placeholder
Citius Oncology, Inc. (NASDAQ:CTOR) Short Interest Update
Citius Oncology, Inc. (NASDAQ:CTOR - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 650,544 shares, an...
MarketBeat·25d ago
News Placeholder
Citius Oncology, Inc. Full Year Loss Increases
(RTTNews) - Citius Oncology, Inc. (CTOR) reported Loss for its full year of -$24.76 million...
Nasdaq News: Markets·27d ago
News Placeholder
Citius Oncology (NASDAQ:CTOR) Issues Quarterly Earnings Results
Citius Oncology (NASDAQ:CTOR - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter...
MarketBeat·27d ago
News Placeholder
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update PR Newswire...
PR Newswire·27d ago
News Placeholder
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business...
PR Newswire·27d ago
News Placeholder
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules Citius Oncology Announces Closing of $18 Million...
PR Newswire·1mo ago
News Placeholder
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules Citius Oncology Announces $18 Million Concurrent Registered...
PR Newswire·1mo ago
News Placeholder
Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East...
PR Newswire·2mo ago
<
1
2
...
>

Latest CTOR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.